BSO LLC

Form 483 issued June 25, 2024 · Lakewood, Colorado

Inspection
Jun 25, 2024
Investigator
Lucila B. Nwatu
Observations
4
Pages
7
FEI number
3011976853

In short: On June 25, 2024, FDA issued a Form 483 with 4 observations to BSO LLC in Lakewood, Colorado (FEI 3011976853) after an inspection that ran Jun 25, 2024. The investigator was Lucila B. Nwatu. Most observations concern production and quality system.

At a glance

Production and quality system account for 4 of 4 observations.

Production2
Quality system2

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include…

  2. 02

    Employees engaged in the manufacture and processing of a drug product lack the training required to…

  3. 03

    Time limits are not established when appropriate for the completion of each production phase to assure…

  4. 04

    EMPI.OYEE(S) SIGNATURE There is a failure to thoroughly review any unexplained discrepancy whether or not the…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at BSO LLC?

FDA listed 4 observations on this Form 483, mostly about production and quality system. The opening words of each observation are shown on this page.

Who inspected BSO LLC?

Lucila B. Nwatu is named on this Form 483, for the inspection of Jun 25, 2024. Each investigator has a profile showing what they cite most.

When was BSO LLC inspected by FDA?

The inspection ran Jun 25, 2024, and the Form 483 is dated June 25, 2024.

How do I get the full Form 483 for BSO LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free